Annual Report 2015–2016

Recommendations

Info

Note 5.4 Administered - Cash Flow Reconciliation Reconciliation of cash and cash equivalents as per administered financial position and administered cash flow statement 2016 2015 $'000 $'000 Cash and cash equivalents as per Administered cash flow statement - - Administered schedule of assets and liabilities - - Discrepancy - - PART 5 financial report Reconciliation of net cost of services to net cash from/(used by) operating activities Net (cost of)/contribution by services (810,333) (835,471) Movements in assets and liabilities Assets Decrease/(Increase) in net receivables 271 1,598 Liabilities (Decrease) in other payable (10,476) (74,630) Net cash (used by) operating activities (820,538) (908,503) 148 Annual Report of the National Health and Medical Research Council 2015–2016
People and Relationships Note 6.1 Provisions 2016 2015 $’000 $’000 Note 6.1: Employee Provisions Leave 5,675 5,248 Total employee provisions 5,675 5,248 Employee provisions are expected to be settled in: No more than 12 months 2,120 2,660 More than 12 months 3,555 2,588 Total employee provisions 5,675 5,248 Significant Accounting Judgements and Estimates In the process of applying the accounting policies listed in this note, the NHMRC has made the following judgements that have the most significant impact on the amounts recorded in the financial statements. The estimated leave provisions involve assumptions based on the expected tenure of existing staff, patterns of leave claims and payouts, future salary movements and discount rates. No accounting assumptions or estimates have been identified that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next reporting period. Accounting Policies Employee benefits Liabilities for ‘short-term employee benefits’ (as defined in AASB 119 Employee Benefits) and termination benefits due within twelve months of the end of the reporting period are measured at their nominal amounts. PART 5 financial report Leave The liability for employee benefits includes provision for annual leave and long service leave. No provision has been made for sick leave as all sick leave is non-vesting and the average sick leave taken in future years by employees of the NHMRC is estimated to be less than the annual entitlement for sick leave. The leave liabilities are calculated on the basis of employees’ remuneration at the estimated salary rates that will be applied at the time the leave is taken, including the NHMRC’s employer superannuation contribution rates to the extent that the leave is likely to be taken during service rather than paid out on termination. The liability for long service leave is recognised and measured at the present value of the estimated future cash flow to be made in respect of all employees at 30 June 2016. The estimate of the present value of the liability takes into account attrition rates and pay increases through promotion and inflation. Separation and Redundancy Provision is made for separation and redundancy benefit payments. The entity recognises a provision for termination when it has developed a detailed formal plan for the terminations and has informed those employees affected that it will carry out the terminations. Superannuation The NHMRC's staff are members of the Commonwealth Superannuation Scheme (CSS), the Public Sector Superannuation Scheme (PSS) or the PSS accumulation plan (PSSap). The CSS and PSS are defined benefit schemes for the Australian Government. The PSSap is a defined contribution scheme. The liability for defined benefits is recognised in the financial statements of the Australian Government and is settled by the Australian Government in due course. This liability is reported in the Department of Finance's administered schedules and notes. The NHMRC makes employer contributions to the employee superannuation scheme at rates determined by an actuary to be sufficient to meet the current cost to the Government, and accounts for the contributions as if they were contributions to defined contribution plans. The liability for superannuation recognised as at 30 June represents outstanding contributions for the final fortnight of the year. Annual Report of the National Health and Medical Research Council 2015–2016 149
Page 1 and 2:
National Health and Medical Researc
Page 3 and 4:
A HEALTHY START TO LIFE NHMRC is co
Page 5 and 6:
CONTENTS ABOUT THE REPORT V PART 1
Page 7 and 8:
ABOUT THE REPORT This report was pr
Page 9 and 10:
PART1 OVERVIEW Chief Executive Offi
Page 11 and 12:
Structural review of NHMRC’s gran
Page 13 and 14:
During the year the NHMRC Council e
Page 15 and 16:
NHMRC’s strategy for health and m
Page 17 and 18:
RESEARCH FUNDING EXPENDITURE Fundin
Page 19 and 20:
PROMOTING EXCELLENCE THROUGH THE NH
Page 21 and 22:
Award Recipient Institution Researc
Page 23 and 24:
Award Recipient Institution Researc
Page 25 and 26:
CASE STUDY “This research is desi
Page 27 and 28:
ASSOCIATE PROFESSOR LEAH COSGROVE C
Page 29 and 30:
PROFESSOR LOUISA JORM WESTERN SYDNE
Page 31 and 32:
PART 2 PERFORMANCE REPORT Chief Exe
Page 33 and 34:
OUTCOMES AND PROGRAM STRUCTURE Thro
Page 35 and 36:
INVESTMENT Goal 5: Participate in d
Page 37 and 38:
TRANSLATION Goal 3: Develop public
Page 39 and 40:
INVESTMENT Create knowledge and bui
Page 41 and 42:
Table 3 Expenditure for Aboriginal
Page 43 and 44:
Figure 6 Expenditure by Science and
Page 45 and 46:
Targeted Calls for Research The out
Page 47 and 48:
GOAL 2: SUPPORT THE HEALTH AND MEDI
Page 49 and 50:
Table 11 People support outcomes fo
Page 51 and 52:
GOAL 3: BOOST DEMENTIA RESEARCH Boo
Page 53 and 54:
GOAL 4: SUPPORT COLLABORATIVE, MULT
Page 55 and 56:
Target 4: Finalise collaborative re
Page 57 and 58:
GOAL 6: SUPPORT RESEARCH THAT WILL
Page 59 and 60:
GOAL 7: PROMOTE ACCESS TO AND USE O
Page 61 and 62:
GOAL 8: IMPROVE THE GRANT APPLICATI
Page 63 and 64:
TRANSLATION Support the translation
Page 65 and 66:
NHMRC also established a separate a
Page 67 and 68:
GOAL 2: SUPPORT THE TRANSLATION OF
Page 69 and 70:
Target 6: Publish an updated Statem
Page 71 and 72:
In early 2016, the NHMRC completed
Page 73 and 74:
GOAL 3: DEVELOP PUBLIC AND ENVIRONM
Page 75 and 76:
Public consultation will be underta
Page 77 and 78:
GOAL 4: REMOVE BARRIERS TO COMMERCI
Page 79 and 80:
Table 17 NHMRC commitments to resea
Page 81 and 82:
Target 2: Improve processes for cli
Page 83 and 84:
GOAL 1: RETAIN HIGH ETHICAL STANDAR
Page 85 and 86:
GOAL 2: STRENGTHEN THE PROCESS FOR
Page 87 and 88:
Outcome 2: Strengthen the process f
Page 89 and 90:
Target 3: Review Ethical Guidelines
Page 91 and 92:
GOAL 4: ADMINISTER THE RESEARCH INV
Page 93 and 94:
PART 3 OPERATING ENVIRONMENT Legisl
Page 95 and 96:
CORPORATE GOVERNANCE Governance bod
Page 97 and 98:
• the Chief Medical Officer or th
Page 99 and 100:
The ERLC assesses applications for
Page 101 and 102:
EXTERNAL SCRUTINY JUDICIAL DECISION
Page 103 and 104:
In accordance with the RMF: • the
Page 105 and 106: Table 19 Freedom of Information req
Page 107 and 108: ACCOUNTABILITY PURCHASING AND PROCU
Page 109 and 110: Table 21 Consultancy services let d
Page 111 and 112: Complaints and their outcomes Of th
Page 113 and 114: CORRECTION OF MATERIAL ERRORS IN PR
Page 115 and 116: CASE STUDY The team studied diaphra
Page 117 and 118: 4 Part PEOPLE MANAGEMENT People 110
Page 119 and 120: Table 24 NHMRC employee overview as
Page 121 and 122: Consultations also raised the impor
Page 123 and 124: LEARNING AND DEVELOPMENT NHMRC’s
Page 125 and 126: Flexible workplace practices CASE S
Page 127 and 128: PART 5 FINANCIAL REPORT Financial P
Page 129 and 130: AGENCY RESOURCE STATEMENT Table 28
Page 131 and 132: INDEPENDENT AUDITOR’S REPORT To t
Page 133 and 134: PART 5 financial report Annual Repo
Page 135 and 136: Statement of Financial Position as
Page 137 and 138: Cash Flow Statement for the period
Page 139 and 140: Administered Reconciliation Schedul
Page 141 and 142: All new standards, amendments to st
Page 143 and 144: Reporting of Administered Activitie
Page 145 and 146: Income and Expenses Administered on
Page 147 and 148: Note 3.2 Non-Financial Assets Note
Page 149 and 150: Revaluations of non-financial asset
Page 151 and 152: Note 3.3 Other Payables 2016 2015 $
Page 153 and 154: Funding Note 5.1 Appropriations Not
Page 155: Note 5.3 Cash Flow Reconciliation R
Page 159 and 160: Managing Uncertainties Note 7.1 Con
Page 161 and 162: Note 7.2 Financial Instruments - Co
Page 163 and 164: Note 7.3 Administered - Financial I
Page 165 and 166: Other Information Note 8: Reporting
Page 167 and 168: 6 PART APPENDICES Appendix 1: Execu
Page 169 and 170: Executive Director, Evidence, Advic
Page 171 and 172: CHAIR OF NHMRC COUNCIL Chair Profes
Page 173 and 174: Australian Capital Territory Dr Pau
Page 175 and 176: Professor Michael Kidd AM Member wi
Page 177 and 178: APPENDIX 3: RESEARCH COMMITTEE The
Page 179 and 180: APPENDIX 5: EMBRYO RESEARCH LICENSI
Page 181 and 182: APPENDIX 7: HEALTH INNOVATION ADVIS
Page 183 and 184: APPENDIX 9: PUBLIC CONSULTATIONS Pu
Page 185 and 186: IREG IRIISS JPco-fuND JPND MREA NAB
Page 187 and 188: PGPA Rule Reference Part of Report
Page 193 and 194: INDEX A Aboriginal and Torres Strai
Page 195 and 196: Cancer 5, 66 National Evidence Base
Page 197: S scholarships, 10, 39-41, 42 scien
show all

Annual Report 2015–2016

Create successful ePaper yourself

Delete template?

Save as template?